Patents by Inventor Raymond Brittingham

Raymond Brittingham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteins Comprising Kallikrein Related Peptidase 2 Antigen Binding Domains And Their Uses
    Publication number: 20260152559
    Abstract: Embodiments of the present invention provide isolated proteins comprising antigen binding domains that bind kallikrein related peptidase 2 (hK2), including monospecific and bispecific antibodies. Additional embodiments of the invention provide polynucleotides encoding the hk2-specific proteins, vectors, host cells, and methods of making and using them.
    Type: Application
    Filed: December 16, 2025
    Publication date: June 4, 2026
    Inventors: Rajkumar Ganesan, John Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Degang Song, Raymond Brittingham, Sathyadevi Venkataramani, Sanjaya Singh, Yonghong Zhao, Fang Yi, Sherry Lynn LaPorte
  • Proteins comprising CD3 antigen binding domains and uses thereof
    Patent number: 12460001
    Abstract: The disclosure provides antigen binding domains that bind cluster of differentiation 3 (CD3) protein, comprising the antigen binding domains that bind CD3?, polynucleotides encoding them, vectors, host cells, methods of making and using them.
    Type: Grant
    Filed: May 26, 2021
    Date of Patent: November 4, 2025
    Assignee: Janssen Biotech, Inc.
    Inventors: Raymond Brittingham, Scott R. Brodeur, Rajkumar Ganesan, Jaclyn Hoover, Steven A. Jacobs, Colleen M. Kane, Jinquan Luo, Sanjaya Singh, Fang Yi, Adam Zwolak, Triveni K. Bhatt, Michael Dennis Feldkamp, Sherry Lynn La Porte
  • PROTEINS COMPRISING CD3 ANTIGEN BINDING DOMAINS AND USES THEREOF
    Publication number: 20250145711
    Abstract: The disclosure provides antigen binding domains that bind cluster of differentiation 3 (CD3) protein, comprising the antigen binding domains that bind CD3?, polynucleotides encoding them, vectors, host cells, methods of making and using them.
    Type: Application
    Filed: September 10, 2024
    Publication date: May 8, 2025
    Inventors: Adam Zwolak, Raymond Brittingham, Scott R. Brodeur, Rajkumar Ganesan, Sherry Lynn La Porte, Jinquan Luo, Fang Yi, Colleen M. Kane, Triveni K. Bhatt
  • Proteins comprising CD3 antigen binding domains and uses thereof
    Patent number: 12084501
    Abstract: The disclosure provides antigen binding domains that bind cluster of differentiation 3 (CD3) protein, comprising the antigen binding domains that bind CD3?, polynucleotides encoding them, vectors, host cells, methods of making and using them.
    Type: Grant
    Filed: March 23, 2022
    Date of Patent: September 10, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Adam Zwolak, Raymond Brittingham, Scott R. Brodeur, Rajkumar Ganesan, Sherry Lynn La Porte, Jinquan Luo, Fang Yi, Colleen M. Kane, Triveni K. Bhatt
  • Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses
    Patent number: 12077585
    Abstract: Embodiments of the present invention provide isolated proteins comprising antigen binding domains that bind kallikrein related peptidase 2 (hK2), including monospecific and bispecific antibodies. Additional embodiments of the invention provide polynucleotides encoding the hk2-specific proteins, vectors, host cells, and methods of making and using them.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: September 3, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Rajkumar Ganesan, John Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Degang Song, Raymond Brittingham, Sathyadevi Venkataramani, Sanjaya Singh, Yonghong Zhao, Fang Yi, Sherry Lynn La Porte
  • Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereof
    Patent number: 12071466
    Abstract: The present disclosure provides for chimeric antigen receptors (CARs) that specifically target a human Kallikrein-2 (hK2), and immunoresponsive cells comprising such CARs, for the treatment of cancer.
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: August 27, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Raymond Brittingham, Rajkumar Ganesan, Sherry La Porte, John T. Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Sanjaya Singh, Degang Song, Sathyadevi Venkataramani, Fang Yi, Yonghong Zhao
  • Proteins Comprising Kallikrein Related Paptidase 2 Antigen Binding Domains And Their Uses
    Publication number: 20240124583
    Abstract: Embodiments of the present invention provide isolated proteins comprising antigen binding domains that bind kallikrein related peptidase 2 (hK2), including monospecific and bispecific antibodies. Additional embodiments of the invention provide polynucleotides encoding the hk2-specific proteins, vectors, host cells, and methods of making and using them.
    Type: Application
    Filed: December 27, 2023
    Publication date: April 18, 2024
    Inventors: Rajkumar Ganesan, John Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Degang Song, Raymond Brittingham, Sathyadevi Venkataramani, Sanjaya Singh, Yonghong Zhao, Fang Yi, Sherry Lynn LaPorte
  • PROTEINS COMPRISING CD3 ANTIGEN BINDING DOMAINS AND USES THEREOF
    Publication number: 20230040715
    Abstract: The disclosure provides antigen binding domains that bind cluster of differentiation 3 (CD3) protein, comprising the antigen binding domains that bind CD3?, polynucleotides encoding them, vectors, host cells, methods of making and using them.
    Type: Application
    Filed: March 23, 2022
    Publication date: February 9, 2023
    Inventors: Adam Zwolak, Raymond Brittingham, Scott R. Brodeur, Rajkumar Ganesan, Sherry Lynn La Porte, Jinquan Luo, Fang Yi, Colleen M. Kane, Triveni K. Bhatt
  • PROTEINS COMPRISING CD3 ANTIGEN BINDING DOMAINS AND USES THEREOF
    Publication number: 20220411504
    Abstract: The disclosure provides antigen binding domains that bind cluster of differentiation 3 (CD3) protein, comprising the antigen binding domains that bind CD3?, polynucleotides encoding them, vectors, host cells, methods of making and using them.
    Type: Application
    Filed: May 26, 2021
    Publication date: December 29, 2022
    Inventors: Raymond Brittingham, Scott R. Brodeur, Rajkumar Ganesan, Jaclyn Hoover, Steven A. Jacobs, Colleen M. Kane, Jinquan Luo, Sanjaya Singh, Fang Yi, Adam Zwolak, Triveni K. Bhatt, Michael Dennis Feldkamp, Sherry Lynn La Porte
  • ANTI-HK2 CHIMERIC ANTIGEN RECEPTOR (CAR)
    Publication number: 20220064254
    Abstract: The present disclosure provides for chimeric antigen receptors (CARs) that specifically target a human Kallikrein-2 (hK2), and immunoresponsive cells comprising such CARs, for the treatment of cancer.
    Type: Application
    Filed: July 23, 2020
    Publication date: March 3, 2022
    Inventors: Raymond BRITTINGHAM, Rajkumar GANESAN, Sherry LA PORTE, John T. LEE, Jinquan LUO, Theresa MCDEVITT, Fei SHEN, Sanjaya SINGH, Degang SONG, Sathyadevi VENKATARAMANI, Fang YI, Yonghong ZHAO
  • Proteins Comprising Kallikrein Related Peptidase 2 Antigen Binding Domains And Their Uses
    Publication number: 20210040210
    Abstract: Embodiments of the present invention provide isolated proteins comprising antigen binding domains that bind kallikrein related peptidase 2 (hK2), including monospecific and bispecific antibodies. Additional embodiments of the invention provide polynucleotides encoding the hk2-specific proteins, vectors, host cells, and methods of making and using them.
    Type: Application
    Filed: July 23, 2020
    Publication date: February 11, 2021
    Inventors: Rajkumar Ganesan, John Lee, Jinquan Luo, Theresa McDevitt, Fei Shen, Degang Song, Raymond Brittingham, Sathyadevi Venkataramani, Sanjaya Singh, Yonghong Zhao, Fang Yi, Sherry Lynn La Porte